HRP20110610T1 - Ms postupci za procjenjivanje glikana - Google Patents

Ms postupci za procjenjivanje glikana Download PDF

Info

Publication number
HRP20110610T1
HRP20110610T1 HR20110610T HRP20110610T HRP20110610T1 HR P20110610 T1 HRP20110610 T1 HR P20110610T1 HR 20110610 T HR20110610 T HR 20110610T HR P20110610 T HRP20110610 T HR P20110610T HR P20110610 T1 HRP20110610 T1 HR P20110610T1
Authority
HR
Croatia
Prior art keywords
glycans
glycan
mass
ratio
similar
Prior art date
Application number
HR20110610T
Other languages
English (en)
Croatian (hr)
Inventor
J. Bosques Carlos
J. Washburn Nathaniel
Zhu Xiangping
Christopher Parsons Ian
Original Assignee
Momenta Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Momenta Pharmaceuticals filed Critical Momenta Pharmaceuticals
Publication of HRP20110610T1 publication Critical patent/HRP20110610T1/hr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HR20110610T 2007-04-16 2011-08-18 Ms postupci za procjenjivanje glikana HRP20110610T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92367707P 2007-04-16 2007-04-16
PCT/US2008/060334 WO2008128221A1 (en) 2007-04-16 2008-04-15 Ms methods to evaluate glycans

Publications (1)

Publication Number Publication Date
HRP20110610T1 true HRP20110610T1 (hr) 2011-10-31

Family

ID=39615678

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110610T HRP20110610T1 (hr) 2007-04-16 2011-08-18 Ms postupci za procjenjivanje glikana

Country Status (14)

Country Link
US (1) US8043863B2 (de)
EP (1) EP2135091B1 (de)
JP (1) JP5116837B2 (de)
AT (1) ATE512366T1 (de)
AU (1) AU2008240074B2 (de)
CA (1) CA2682750A1 (de)
CY (1) CY1111811T1 (de)
DK (1) DK2135091T3 (de)
ES (1) ES2367210T3 (de)
HR (1) HRP20110610T1 (de)
PL (1) PL2135091T3 (de)
PT (1) PT2135091E (de)
SI (1) SI2135091T1 (de)
WO (1) WO2008128221A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2135091T3 (da) 2007-04-16 2011-09-19 Momenta Pharmaceuticals Inc MS-fremgangsmåder til evaluering af glykaner
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
WO2014143205A1 (en) 2013-03-12 2014-09-18 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US8956830B2 (en) 2013-03-14 2015-02-17 Momenta Pharmaceuticals, Inc. Methods of cell culture
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
US20160108450A1 (en) 2013-05-02 2016-04-21 Momenta Pharmaceutcals, Inc. Sialylated glycoproteins
EP2996772B1 (de) 2013-05-13 2018-12-19 Momenta Pharmaceuticals, Inc. Verfahren zur behandlung von neurodegeneration
EP3052640A2 (de) 2013-10-04 2016-08-10 AbbVie Inc. Verwendung von metallionen zur modulation von proteinglykosylierungsprofilen rekombinanter proteine
WO2015057622A1 (en) 2013-10-16 2015-04-23 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
JP6471606B2 (ja) 2015-02-23 2019-02-20 Agc株式会社 積層体の剥離装置及び剥離方法並びに電子デバイスの製造方法
US11719704B2 (en) 2015-12-30 2023-08-08 Momenta Pharmaceuticals, Inc. Methods related to biologics

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3383587B2 (ja) * 1998-07-07 2003-03-04 株式会社東芝 静止画像連続情報記録方法と光ディスクと光ディスクの情報再生装置と情報再生方法
JP4828795B2 (ja) * 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
EP1587408A4 (de) * 2002-12-20 2007-09-05 Momenta Pharmaceuticals Inc Glycan-marker zur diagnose und überwachung von erkrankungen
DE112004001212B4 (de) * 2003-07-03 2014-07-24 Waters Technologies Corp. (N.D.Ges.D. Staates Delaware) Verfahren für die Analyse von Isotopensignaturen und die Massenanalyse
US7138228B2 (en) * 2003-09-05 2006-11-21 Regents Of The University Of California Protein O-sulfonation
WO2005111627A2 (en) 2004-04-15 2005-11-24 Massachusetts Institute Of Technology Methods and products related to the improved analysis of carbohydrates
US20090012714A1 (en) * 2004-08-04 2009-01-08 Yasushi Ishihama Test of amino acid sequence constituting peptide using isotopic ratio
JP2006047239A (ja) * 2004-08-09 2006-02-16 National Institute Of Advanced Industrial & Technology 硫酸化単糖の同定方法及び硫酸化単糖異性体混合物の分析方法
JP2009507212A (ja) * 2005-09-02 2009-02-19 オーストラリアン ヌークリア サイエンス アンド テクノロジー オーガニゼイション 同位体比質量分析計および同位体比の決定方法
DK2135091T3 (da) 2007-04-16 2011-09-19 Momenta Pharmaceuticals Inc MS-fremgangsmåder til evaluering af glykaner

Also Published As

Publication number Publication date
CA2682750A1 (en) 2008-10-23
US8043863B2 (en) 2011-10-25
ATE512366T1 (de) 2011-06-15
AU2008240074B2 (en) 2013-02-21
SI2135091T1 (sl) 2011-10-28
DK2135091T3 (da) 2011-09-19
JP2010525327A (ja) 2010-07-22
US20100133430A1 (en) 2010-06-03
ES2367210T3 (es) 2011-10-31
EP2135091B1 (de) 2011-06-08
AU2008240074A1 (en) 2008-10-23
CY1111811T1 (el) 2015-10-07
PT2135091E (pt) 2011-09-01
WO2008128221A1 (en) 2008-10-23
JP5116837B2 (ja) 2013-01-09
EP2135091A1 (de) 2009-12-23
PL2135091T3 (pl) 2011-11-30

Similar Documents

Publication Publication Date Title
HRP20110610T1 (hr) Ms postupci za procjenjivanje glikana
JP2010525327A5 (de)
Curtis et al. p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles
Holderness et al. Polysaccharides isolated from Acai fruit induce innate immune responses
Vida et al. Role of macrophages in age-related oxidative stress and lipofuscin accumulation in mice
Kwon et al. Porphyran induces apoptosis related signal pathway in AGS gastric cancer cell lines
Wang et al. Ginger polysaccharides induced cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells
Park et al. The differential effect of high and low molecular weight fucoidans on the severity of collagen‐induced arthritis in mice
Rafiquzzaman et al. Antioxidant activity of glycoprotein purified from Undaria pinnatifida measured by an in vitro digestion model
Calabrò et al. Triggering of suicidal erythrocyte death following boswellic acid exposure
Zhao et al. Improving the activity of Lycium barbarum polysaccharide on sub-health mice
Toliopoulos et al. Resveratrol diminishes platelet aggregation and increases susceptibility of K562 tumor cells to natural killer cells
Luzak et al. Extract from Ribes nigrum leaves in vitro activates nitric oxide synthase (eNOS) and increases CD39 expression in human endothelial cells
Klíma et al. Differential regulation of galectin expression/reactivity during wound healing in porcine skin and in cultures of epidermal cells with functional impact on migration.
Veach et al. Anti-platelet and anti-thrombogenic effects of shikimic acid in sedentary population
Rodrigues et al. An anti-dengue and anti-herpetic polysulfated fraction isolated from the coenocytic green seaweed Caulerpa cupressoides inhibits thrombin generation in vitro
Liu et al. Effect of sonication on different quality parameters of Pinus massoniana pollen
Gnanamangai et al. Analysis of antioxidants and nutritional assessment of date palm fruits
Paulose et al. Effect of grape seed extract on the bond strength and durability of resin-dentin interface
Mohan et al. Anticancer potential of Tinospora cordifolia and arabinogalactan against benzo (a) pyrene induced pulmonary tumorigenesis: a study in relevance to various biomarkers
Reboleira et al. Brown seaweeds
CN102660615B (zh) 一种抗氧化肽及其制备方法
Krichen et al. Sulfated polysaccharides from Tunisian fish skins: Antioxidant, DNA damage protective effect and antihypertensive activities
Kuntz et al. Extracts from Brassica oleracea L. convar. acephala var. sabellica inhibit TNF-α stimulated neutrophil adhesion in vitro under flow conditions
Wong et al. Modulation of platelet functions by crude rice (Oryza sativa) bran policosanol extract